ABSTRACT The nucleotide sequence of a gene in plasmid pE194 responsible for erythromycin-induced resistance, in-
occupancy in sequence 1, and in the resultant redistribution, 2 associates with 3, freeing 4 and thereby freeing the ribosome binding site sequestered by the association of 3 and 4. Sequence alterations at the 5' end of the 29,000-protein coding region associated with mutation to constitutive expression have been localized to the inverted complementary repeats, and determination of base changes in eight mutants are all capable of reducing the stability of the postulated stems in a manner consistent with predictions made by the model.
The mechanism of erythromycin resistance in clinical bacterial isolates involves specific modification after synthesis-namely, N6-dimethylation of adenine in 23S ribosomal RNA-which markedly reduces the affinity between erythromycin and the ribosome (1) (2) (3) . Some properties of inducible strains and references to earlier work have been covered in a review (3) . Cells exposed to 10-100 nM erythromycin for induction (optimal inducing concentration range) acquire resistance to concentrations exceeding 100 ,uM within 40-60 min, and in the course of induction the entire culture acquires the capability to express the resistance phenotype (2, 4) . In the present study, data from
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 7079 preliminary cloning experiments suggested that regulation of resistance was exerted at a level other than transcription. Based on our experimental findings, we propose a mechanism of gene regulation in which an induced conformational change in the mRNA converts it from a form inactive in translation to one that is active as a result of complex formation between (i) erythromycin, (ii) sensitive ribosomes, and (iii) a regulatory sequence in mRNA.
MATERIALS AND METHODS Bacterial Strains and Plasmids. pE194 and pC194 are plasmids found originally in Staphylococcus aureus that specify resistance to erythromycin and chloramphenicol, respectively. Both plasmids can be introduced into Bacillus subtilis by transformation, during which they express their respective resistance phenotypes, and their use as cloning vehicles in B. subtilis has been described (5). pC194 DNA and pE194 DNA used for sequence determinations were prepared as described (6) . Constitutive mutants of pE194, selected with tylosin, and their respective plasmid DNA preparations were obtained using S. aureus RN2442 (a strain that carries pE194) provided by R. P. Novick (7, 8) . The recombinant experiments were performed using B. subtilis MI112 as recipient, as described by Tanaka (9, 10) . pTL11, provided by T. Tanaka (10) , served as source of the trimethoprim-resistance determinant.
Cloning the pE194 Taq I A Fragment Using pC194. pC194 contains five Taq I sites (recognition sequence: T-C-G-A) of which two belong to the Cla I subgroup (A-T-C-G-A-T), whereas pE194 contains three Taq I sites of which one belongs to the Cla I subgroup. The ligation mixture contained a limit pE194 Taq I digest and a partial pC194 Cla I digest in a 1:1 ratio. Transformants selected for erythromycin resistance were screened for chloramphenicol resistance. Covalently closed circular (form I) DNA was prepared from three selected transformants resistant to chloramphenicol and inducibly resistant to erythromycin. The purified form I DNA obtained from these strains was digested with Taq I, and the resultant digest was fractionated by polyacrylamide gel electrophoresis. This procedure yielded five fragments for pC194, six fragments for one of the recombinants (of which one band was indistinguishable in mobility from the pE194 Taq I fragment A), and seven fragments for the other two recombinants in which apparently both the Taq I A and B fragments were cloned. All enzymes used in these studies were purchased from New England BioLabs except for Cla I, which was purchased from Boehringer. The sequence of the Taq I A fragment was determined by the method of Maxam and Gilbert (11) .
Sequence Alterations in Constitutive Mutants of pE194.
A set of independent constitutive S. aureus mutants was selected by using enriched medium supplemented with 10 ,g of tylosin Abbreviation: S-D, Shine-Dalgarno sequence.
per ml. After locating the site of mutation near the 5' end of the sequence that codes for the 29,000 protein by means of recombinant mapping techniques, sequence determinations were performed using DNA obtained from each of the mutants.
RESULTS AND DISCUSSION Restriction Endonuclease Cleavage Sites in pE194. A map of pE194 listing the pertinent restriction endonuclease cleavage sites is shown in Fig. 1 . Also indicated are genes coding for three proteins with molecular sizes of 15,000, 29,000, and 45,000 daltons deduced from the DNA sequence. They are referred to as the "15,000," "29,000," and "45,000" proteins, respectively. Experimental data pertaining to the 15,000 and 45,000 proteins will be presented elsewhere. The object of the present study was the region containing the sequence that codes for the 29,000 protein-the protein that mediates expression of the erythromycin-resistance phenotype.
Recombinant DNA Studies; Cloning the Taq I Fragments of pE194. Our most informative results were obtained from cloning a limit Taq I digest of pE194 by using a partial Cla I digest of pC194 as cloning-vehicle preparation. Erythromycin-resistant transformant clones were obtained containing the Taq I A fragment. One of these containing the Taq I A fragment alone showed inducible resistance when tested with disks containing either erythromycin and tylosin. These findings suggested that the Taq I B and C fragments of pE194 were not necessary for either resistance or its regulation, and that the Taq I A fragment alone could code for both the erythromycin-resistance determinant and its associated regulatory mechanism.
Insertional Inactivation of Erythromycin Resistance. The fragment chosen for insertion into the Bcl I site (recognition sequence: T-G-A-T-C-A) contained a trimethoprim-resistant dihydrofolate reductase determinant flanked by two Bgl II sites (A-G-A-T-C-T) from pTLll, which could be ligated, therefore, into the Bcl I site. Trimethoprim-resistant, erythromycin-sensitive transformant clones were obtained, and form I DNA prepared from one of these clones was analyzed by the heteroduplex method (12) and by polyacrylamide gel electrophoresis. The analyses showed that the trimethoprim-resistance determinant was inserted into the BcR I site. We conclude that the 29,000 protein is necessary for expression of erythromycin resistance and that the Bc1 I site interrupts the continuity of the coding sequence for this protein.
Localization of a Control Element for Erythromycin Resistance. To localize sequence alterations responsible for expression of the resistance phenotype, we prepared four recombinant plasmids using pE194 restriction fragments from inducible and constitutive pE194 DNA as outlined in Fig. 2 . pE194 DNA was first cut with Bc1 I and Pst I (each of which cuts pE194 once), followed by religation of the two complementary fragments from inducible pE194 and from a constitutive mutant. After transformation, erythromycin-resistant transformant clones were selected and scored with respect to whether resistance was inducible or constitutive. For the Pst I-BcR I recombinant, this procedure allowed us to localize the determinant of inducible (or constitutive) expression in the smaller of the two fragments (i.e., between 0.68 and 0.07 map units, proceeding in a clockwise direction). A similar set of constructions, in which fragments prepared by digestion with Msp I were used, pointed to the region between 0.29 and 0.86 map units as the location of the regulatory determinant. These independent determinations narrow the site of mutation to the interval between 0.68 and 0.86 map units-an interval which covers the 5 2 . Localization of the erythromycin control region. Heterologous plasmids were constructed from inducible and constitutive pE194 by using restriction endonucleases as indicated. After transformation into B. subtilis, erythromycin-resistant transformants were selected and scored with respect to whether their phenotype was inducible or constitutive. The enzymes used to obtain the fragments used in the constructions and the respective source phenotypes are indicated below. The thick segments were derived from inducible pE194 and the thin segments were derived from a constitutive mutant. RNA polymerase formed a 0.6 M KCI-resistant complex in the absence of added triphosphates only with the Hinf I B and Mbo I D fragments by using the method of Taylor and Burgess (13) (data not shown). The finer localization represents the small overlap between the two fragments.
Nucleotide Sequence of the Taq I A Fragment. In the results presented below, "residue" refers to an absolute enumeration based on the sequence of the entire plasmid (3727 base pairs). In view of the noteworthy biological properties of the Taq I A fragment, we report its nucleotide sequence (Fig. 3) . The DNA sequence contains two open reading frames capable of coding for two peptides containing 19 and 243 amino acids, respectively; the latter corresponds to a protein with a calculated molecular size of 29,000 daltons. Immediately preceding the 29,000-protein coding sequence we note a region that resembles promoters described in other systems; an interpretive summary of the properties of this region is shown in Figs. 3 and 4 At the 3' end of the putative mRNA transcript, sites for 29,000-protein translation termination and transcription termination are also indicated (Fig. 3) . The transcription terminator contains a complementary inverted repeat followed by oligo-(T) similar to that found in other systems (15) (16) (17) .
A Fig. 3 and discussed in this paper. The labels used correspond to those used in Fig. 3. of expression of 29,000-protein function, we must explain the regulation of expression in terms of the structure of this region and propose the following model to account for our observations. The association of sequences 1 plus 2 and 3 plus 4 in mRNA forms one of several possible sets of base-paired stem combination; we postulate (i) that this conformation corresponds to the low rate of expression since S-D-2 is trapped by 3 plus 4 stem formation, and (ii) that disruption of the integrity of 3 plus 4 to free up S-D-2 constitutes the key event in induction. We postulate further (iii) that during induction, ribosomes first bind to S-D-1 to initiate synthesis of the leader peptide. In the presence of subinhibitory inducing concentrations of erythromycin, the ribosomes become "stalled" in sequence 1; as a consequence, 2 is diverted to form an energetically favored association with 3, which frees 4 and therefore S-D-2, which can then bind ribosomes permitting them to initiate synthesis of the 29,000 protein. The control region that we have sequenced shows some similarity to attenuator regions associated with operons responsible for the biosynthesis of amino acids. Some of the properties of these attenuator regions in various systems have been discussed in reviews of the subject (16, 17) . In contrast, the erythromycin control region contains no obvious transcription termination signal; therefore, we infer that the function of this region differs from that of the attenuators reviewed above.
<S-D-2> ------2-----IXXXXXXXXXXXXXXI------3----XXXXI-----2-----jI--3--IXXXXXXXXXXXI--4--l
Mutations in the Control Region: Supporting Evidence for the Model. Several mutants that we have analyzed support this model. Eight independent constitutive S. aureus mutants selected using tylosin were randomly chosen for sequence analysis. The distribution of these mutants is shown in Fig. 4 ; three separate independent occurrences of C to A in 3, and G to A in 4 point to the importance of the role of 3 plus 4 pairing stability in maintaining the repressed state. The involvement of a single C-G base pair in the 3 plus 4 stem in six of eight independent mutants suggests that these two distinct mutable residues, separated by 13 bases, have biological significance as a base pair in ivo; loss of either the C or the G at this critical stem site would also result in loss of the integrity of the GCG base pair immediately adjacent to the loop, owing to a cooperative effect and favoring dissociation of 3 plus 4. We found one constitutive mutant in which the entire sequence 1 and the 5' end of the sequence that codes for the leader peptide (61 bases) were deleted as indicated in Fig. 4 . In this deletion mutant, any negative regulatory effects exerted by 1 plus 2 pair formation would be bypassed, according to the model proposed. Finally, one occurrence of a point mutation (C to A) was found in 1, which would serve to weaken its association with 2. The pivotal role postulated for 2 requires that its integrity be maintained in mutation to constitutivity, whereas the opposite is true for 1, 3, and 4; in agreement with this expectation, none of the mutants found so far involves sequence 2. Refinements to the Model for Induction. (21) have made detailed studies of inhibition produced by erythromycin. They noted that erythromycin can inhibit at an early stage after initiation, before many amino acid residues have been incorporated. Vazquez (22) in a review has concluded that the inhibitory action of erythromycin "is preferential for polysomes synthesizing short (di-to penta-) peptides, and the efficiency of inhibition depends on the amino acid composition of the peptide." In the context of the model for inducible resistance, this is precisely the type of inhibitory action required for an antibiotic to have significant inducing activity. How the pattern of codon utilization in the leader peptide optimizes its function in induction, or whether the leader peptide performs some specific function is not yet clear; however, the small size of peptides synthesized in an erythromycin-inhibited system compares favorably with the peptide length needed (12-15 residues) to occupy sequence 1 and to prevent formation of a double-stranded complex with sequence 2. The significant attributes of the macrolide, lincosamide, and streptogramin type B antibiotics relevant to their effectiveness as inducers may be that (i) it is only the macrolide, lincosamide, and streptogramin type B antibiotics to which the minority population of methylated ribosomes postulated to be normally present is resistant, and (ii) the macrolide, lincosamide, and streptogramin type B antibiotics may inhibit ribosome function in a way consonant with ribosome stall in the leader peptide region.
